Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJ9 | ISIN: CA8475771033 | Ticker-Symbol: SD4
Frankfurt
03.09.25 | 08:00
0,970 Euro
+5,43 % +0,050
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPECTRAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
SPECTRAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4960,53523:00

Aktuelle News zur SPECTRAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.08.Spectral Medical is a stock to buy now, this analyst says4
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln
25.08.Spectral Medical Inc: Spectral receives $3M (U.S.) tranche from Vantive1
25.08.Stocks in Play: Spectral Medical Inc.2
25.08.Spectral Medical Inc.: Spectral Medical Receives US$3 Million From Vantive247TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
13.08.XFRA SD4: WIEDERAUFNAHME/RESUMPTION265FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
13.08.XFRA SD4: AUSSETZUNG/SUSPENSION103DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSPECTRAL MEDICAL...
► Artikel lesen
13.08.Spectral Medical Inc: Spectral's PMX reduces mortality in septic shock trial4
12.08.Spectral Medical Inc.: Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock115Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary...
► Artikel lesen
08.08.Spectral Medical GAAP EPS of $0.00, revenue of $0.81M2
08.08.Spectral Medical Inc.: Spectral Medical Announces Second Quarter and Provides Corporate Update118Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic...
► Artikel lesen
04.07.Spectral Medical Inc: Spectral files preliminary prospectus for securities2
04.07.Spectral Medical Inc. Announces Filing of Base Shelf Prospectus3
06.06.Spectral Medical Inc: Spectral Medical shareholders okay all matters at AGM2
06.06.Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders117TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
09.05.Spectral Medical reports Q1 results3
09.05.Spectral Medical Inc.: Spectral Medical Announces First Quarter and Provides Corporate Update166Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...
► Artikel lesen
08.05.Spectral Medical is "fundamentally undervalued", Paradigm says2
07.05.Spectral Medical Inc: Spectral Medical to issue $10M (U.S.) note to Vantive2
07.05.Stocks in Play: Spectral Medical Inc.1
07.05.Spectral Medical Inc.: Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive263• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1